´ºÓêÖ±²¥app

´ºÓêÖ±²¥app

Completion of Follow-Up Observations in Clinical Study on Regenerative Medicine Using iPS Cell-Derived Neural Stem/Progenitor Cells to Treat Subacute Spinal Cord Injuries

Publish: April 02, 2025
Public Relations Office

April 2, 2025

´ºÓêÖ±²¥app School of Medicine

´ºÓêÖ±²¥app Hospital

National Hospital Organization Osaka National Hospital

National Hospital Organization Murayama Medical Center

´ºÓêÖ±²¥app Hospital has completed the scheduled follow-up observations and data collection for all four cases in its clinical study on regenerative medicine using iPS cell-derived neural stem/progenitor cells to treat subacute spinal cord injuries.

Moving forward, we will promptly submit a comprehensive report and summary to the Minister of Health, Labour and Welfare in accordance with the Act on Securing Safety of Regenerative Medicine and related regulations.